NCT03198988

Brief Summary

Total participants in the "Functionality and Accuracy of the smART System in Real-Life ICU Settings" are 10 participants - in the current Jefferson study site there were 8 participants and in the Sheba study site (identifier NCT03689985) there were 2 participants. This study is conducted in order to validate the functionality and accuracy of the smART™ System in a real-life ICU setting. The smART™ Feeding Tube System is a novel system with nasogastric tube developed by ART Medical (Healthcare) Ltd, based on sensor-lined tubes that transmit real-time information to an external console. The smART™ feeding tube is equipped with reflux sensors which alert when gastric contents regurgitating into the esophagus. In addition, the smART™ feeding tube is equipped with sensors designed to provide information about the location of the tube thus assisting in reducing the incident of misplacement during first positioning. The smART™ feeding tube is also automatically and in real-time stops feeding if the feeding tube moves out of position during ongoing use or detect gastric content in esophagus. Furthermore, smART™ Feeding Tube System can guide operator to correctly re-position the tube. Lastly the smART™ Feeding Tube System is equipped with an anti-reflux mechanism and automatic Gastric Residual Volume (GRV).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 26, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

October 26, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 28, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 28, 2020

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

February 13, 2023

Completed
Last Updated

February 13, 2023

Status Verified

July 1, 2021

Enrollment Period

2.5 years

First QC Date

June 12, 2017

Results QC Date

August 3, 2022

Last Update Submit

January 17, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • Number of Participants for Whom the System is Able to Accurately Guide and Ensure Correct Initial Feeding Tube Placement , Verified by X-ray

    Enrollment visit

  • Number of Tube "Out of Position" Alerts During Ongoing Use

    Any patient , in which the system alerted of tube out of position , the staff verified this according to the tube markings and if mispositioning occurred, this was documented the event in the CRF "out of position"

    Enrollment day up to 7 days

  • Number of Automatic System Generated Feeding Stops in Response to Tube Displacement.

    In order to prevent aspiration, the system software automatically pinches the feeding tube. Verification of the functionality of automatic feeding cessation when tube displacement is detected was done as part of the formal verification of the system

    From insertion of feeding tube up to its removal , an average of 7 days.

  • Number of Major Reflux Event That Lead to Automatically Stops Feeding

    Overfeeding is the intolerance of the stomach to feeding material that causes reflux. There are two types of reflux events as defined by the system; minor-reflux and massive-reflux. Both types of reflux events are detected by the level of fluids interacting with the sensors, the severity is defined by gastric content reaching above the lower esophageal sphincter (LES): 1. Minor reflux is defined as gastric content that did not pass the balloon located in the center of the esophagus. 2. Massive reflux is defined as gastric content that reaches immediately above the balloon.

    From insertion of feeding tube up to its removal , an average of 7 days.

  • Average Duration of Balloon Inflation in Response to a Reflux Episode.

    Massive reflux of gastric content can aspirate into the lungs and cause pneumonia. The system detects the reflux event and will (according to an algorithm) stop the feeding and or inflate a balloon and evacuate gastric residuals from the stomach to lower the risk of aspiration.

    From insertion of feeding tube up to its removal , an average of 7 days.

Secondary Outcomes (2)

  • Recording of Impedance Detected by the System and Correlation to Patient Positioning.

    From insertion of feeding tube up to its removal , an average of 7 days.

  • Number of Participant With Change in Ventilator Associated Pneumonia (VAP) and/or Acute Respiratory Distress Syndrome (ARDS) as a Measure of Effectiveness in Reducing Aspiration of Gastric Contents

    56 - 168 hours per patient

Study Arms (1)

General

EXPERIMENTAL

One arm study: smART Feeding Tube System.

Device: smART Feeding Tube System

Interventions

Replacing generic feeding tube with smART Feeding Tube System.

General

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and females 18 years or older
  • Patient has already been admitted to ICU
  • Patient requires enteral feeding
  • Patients receiving Proton Pump Inhibitors (PPI) therapy
  • Informed consent by independent physician and next of kin
  • ICU ventilated patients

You may not qualify if:

  • Patients with anomalies or diseases of the esophagus and or stomach.
  • Patients with known sensitivities or allergies to any of the feeding tube materials
  • Inability to place patient in semi-Fowler's position.
  • Any clinically significant abnormality upon physical examination which may, in the opinion of the investigator, pose difficulty in inserting the feeding tube (e.g. cervical spine disorder)
  • Pregnancy
  • Recent abdominal surgery (less than 30 days)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, 19107, United States

Location

MeSH Terms

Conditions

Pneumonia, Aspiration

Condition Hierarchy (Ancestors)

PneumoniaRespiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract Diseases

Results Point of Contact

Title
Mrs Shirly Steinlauf
Organization
ART MEDICAL

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 12, 2017

First Posted

June 26, 2017

Study Start

October 26, 2017

Primary Completion

April 28, 2020

Study Completion

April 28, 2020

Last Updated

February 13, 2023

Results First Posted

February 13, 2023

Record last verified: 2021-07

Locations